Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
BREAKING NEWS – EARLY PRESS RELEASE APP News – April 1st 2016 Sherlock Holmes: Well, I am excited about taking on the case of yet another frightening new microbe… Dr. Watson: Yes, it is a particularly virulent bug, no treatment seems to be effective. SH: What else is new! It Continue reading Sherlock Holmes and Dr. Watson Reflecting on Recent Trouble in Microbe-Land
Isavuconazole is a potent triazole; like Voriconazole, it has garnered an indication for invasive aspergillosis. However, it failed where other azole antifungals succeeded: in a pivotal trial, not yet published, the drug was inferior to Caspofungin in the treatment of invasive candidiasis/candidemia in non-neutropenic patients [1]. To provide some background: in Continue reading The Cresemba Candidemia Gamble – Rien Ne Va Plus
Sometimes one comes across a particularly well-written policy document which summarizes the status quo of antimicrobial resistance by connecting and synthesizing data from all kinds of sources into a coherent framework. The 2015 OECD Report on Antimicrobial Resistance in G7 Countries and Beyond: Economic Issues, Policies and Options for Action Continue reading Overcoming Antimicrobial Resistance – A European Report Recommends Deja-Vu Action